Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

The case for HER2/neu as a therapeutic target for gynecologic malignancies.

Goyne HE, Cannon MJ. The case for HER2/neu as a therapeutic target for gynecologic malignancies. Immunotherapy. 2012 Aug; 4(8):781-4.

View in: PubMed

collapse authors with profiles